Bilaketaren emaitzak - Steven Santiago
- Erakusten 1 - 3 emaitzak -- 3
-
1
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV nork Sonia Vibhakar Patel, Dushyantha Jayaweera, Keri N. Althoff, Joseph J. Eron, Janna Radtchenko, Anthony Mills, Graeme Moyle, Steven Santiago, Paul E. Sax, Jason Gillman, Karam Mounzer, Richard Elion, Gregory Huhn
Argitaratua 2020Artigo -
2
Efficacy and Safety of Nevirapine Extended-Release Once Daily versus Nevirapine Immediate-Release Twice-Daily in Treatment-Naive HIV-1-Infected Patients nork Joseph Gathe, Jaime Andrade‐Villanueva, Steven Santiago, Andrzej Horban, Mark Nelson, Pedro Cahn, Johannes R. Bogner, David Spencer, Daniel Podzamczer, Chan‐Loi Yong, Thuy Nguyen, Wei Zhang, Murray Drulak, Anne‐Marie Quinson
Argitaratua 2010Artigo -
3
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults nork Frances Priddy, Deborah D. Brown, James G. Kublin, Kathleen Monahan, David P. Wright, Jacob Lalezari, Steven Santiago, Michael Marmor, Michelle Lally, Richard M. Novak, Stephen J. Brown, P.P. Kulkarni, Sheri Dubey, Lisa Kierstead, Danilo R. Casimiro, Robin Mogg, Mark J. DiNubile, John W. Shiver, Randi Y. Leavitt, Michael Robertson, Devan V. Mehrotra, Erin Quirk
Argitaratua 2008Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Immunology
Internal medicine
Medicine
Adverse effect
Alternative medicine
Human immunodeficiency virus (HIV)
Pathology
Placebo
Viral load
Virus
Antibody
Antiretroviral therapy
Clinical endpoint
Clinical trial
Coinfection
ELISPOT
Emtricitabine
Gastroenterology
HIV vaccine
Hepatitis C
Hepatitis C virus
Immune system
Immunogenicity
Neutralizing antibody
Nevirapine
Randomized controlled trial
Regimen
Ribavirin
T cell
Vaccination